Inventor · disambiguated record
Michael E. Mertzman
Also filed as: MERTZMAN MICHAEL E · MERTZMAN MICHAEL EDWARD
12 granted patents·8 pending applications·69 citations·filing 2006–2024
88Inventor score
Top patents by PatentIndex Score
20 records- 0198US11866414B2Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jan 9, 2024·11 cites·23 claims
- 0293US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0392US9663467B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·21 cites·7 claims
- 0490US9987266B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 5, 2018·9 cites·1 claims
- 0588US9315494B2Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 19, 2016·14 cites·11 claims
- 0682US2025163004A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0781US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
- 0879US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 0979US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1079US2024190829A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1178US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1277US8153804B2Aryl pyridines and methods of their useAUGERI DAVID J·Filed 2006·Granted Apr 10, 2012·5 cites·15 claims
- 1375US11884650B2Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jan 30, 2024·0 cites·6 claims
- 1475US2024124421A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1567US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 1660US2024270723A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1760US2024317718A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1859US2025066322A1Substituted heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1951US12240840B2Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alphaBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·2 claims
- 2046US10836770B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 17, 2020·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Michael E. Mertzman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →